Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. Copyright 2007-2011 by StrategyDriven, Inc.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

MAY 20, 2014

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. For entrepreneurs, why start something new in such an environment?

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

AUGUST 3, 2012

Although many analysts and even executives have stated that established pharmaceutical firms are cutting their R&D budgets, the fact is that ongoing R&D expenditures on internal projects remain just as high in 2011 and 2012 as they have for the past decade — and those levels are historical highs.

Licensing 13

Licensing Depreciation Pharmaceuticals Budgeting 13

Harvard Business Review

DECEMBER 12, 2012

Based on data covering the period from 2005 to 2011, it charts how globalization has evolved since the onset of the financial crisis at the global, regional, and national levels. Improving a country's domestic business environment can go a long way toward strengthening its international connections.

Report 15

Report Merchandising GDP Globalization 15

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. As leaders, do physicians create a more sympathetic and productive work environment for other clinicians, because they are “one of them”?

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

AUGUST 17, 2012

Needless to say, this approach has not worked in reaching lower and middle income segments of emerging markets that require price and marketing strategies that fit both consumers' ability to pay and the nature of the purchasing environment, which is often more diffuse than in the U.S. irketi in 2011 provided expansion in Turkey.

Company 11

Company Pharmaceuticals Business Model Fixed Costs 11

Strategy Driven

MARCH 18, 2011

Companies today operate in a business environment that encourages incoherence. But even in such an environment, capabilities are essential – for example, working with the government to ensure distribution, or negotiating labor contracts to secure continued access to talent. Copyright 2007-2011 by StrategyDriven, Inc.

Resources 52

Resources Industry System Strategy 52